Widecells Group Plc (LON:WDC) CEO João Andrade and Vice President of Wide Academy Alan Greenberg talk to DirectorsTalk about its strategic update on WideAcademy – its 100% owned education and training division. João Andrade explains how the success of WideCells is predicated on that of WideAcademy and vice versa. Alan explains the mandate for wideAcademy, how medical professionals and families access information on cutting edge stem cell technology currently and how this is all about to change, who is working with him and where he sees WideAcademy in the next 6-12 and 12-18 months.
WideCells Group PLC is building an integrated stem cell services company, focused on making stem cell treatments accessible and affordable. The Directors believe that the use of cord blood stem cells for transplant will drive one of the next important phases in medicine and is therefore developing market leading products in complementary, strategic areas which are designed to take advantage of substantial market opportunities in one of the fastest growing segments in the healthcare industry. With this in mind, it has created three divisions:
· CellPlan: the world’s first stem cell healthcare insurance plan with financial cover for medical treatment, travel and accommodation expenses and concierge service to manage the treatment process
· WideCells: the Institute of Stem Cell Technology has been established and is based in the University of Manchester Innovation Centre to focus on stem cell research and regenerative medicine. WideCells also has international cryogenics divisions specialising in stem cell storage.
· WideAcademy: developing an education and training division to promote awareness of the benefits of stem cell storage across the global general practice community.
The Group has built an experienced senior management team that has been integral to the development of its growth and business to date.